NHS patients receive UK-donated plasma medicines for first time in 30 years
Octapharma supports NHS in building resilient supply chain Octapharma has announced that, for the first time in almost 30 years,...
adminph
SECuRE trial pre-chemo participants experience PSA level drops
Cohort expansion phase commences with promising results The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation...
Rotherham NHS Foundation Trust enhances patient engagement
Innovative digital transformation leads to significant improvements To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has...
Future drugs may snap supply chain fueling breast cancer
Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells hijack...
Bas Vorsteveld
Kenvue appoints Bas Vorsteveld as Managing Director for Northern Europe Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee...
Researchers reveal key mechanism behind bacterial cancer therapy
A research team led by Prof. LIU Chenli from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of...
Centauri therapeutics selects first ABX-01 clinical candidate
Lead candidate for lung infections moves to human trials Centauri Therapeutics Limited has announced the selection of its first clinical...
Common malaria drug repurposed to fight cancer
Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at...
Professor Dr Uli Brödl
Grünenthal has appointed Professor Dr Uli Brödl as CSO Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief Scientific Officer (CSO)...
Blood cancer patients face treatment access disparity
New research highlights NHS approval gap compared to other cancers Research from the Blood Cancer Alliance reveals a significant disparity...
Pharma unphased
The critical step of navigating post-approval phase Entering the post-approval phase marks a critical pivot for pharmaceutical companies, shifting their...
Chain reaction
Pharmaceutical manufacturers in the UK have been navigating complex supply chains for the longest time, balancing the dual pressures of...
Switching between defense and attack – immune cells with dual role
LMU researchers have shown that a particular type of immune cell acts more flexibly than previously thought - with potential...
Datapharm collaborates with VIDAL to improve medicines information access in France
New partnership to integrate SRD search technology Datapharm, a UK-based provider of medicines information, has announced its expansion into Europe...
Brainomix partners with Medtronic to enhance stroke care
New collaboration aims to integrate AI solutions for treatment Brainomix, a leader in stroke AI imaging software, has announced a...
GSK completes acquisition of IDRx, Inc.
GSK plc (LSE/NYSE: GSK) announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, clinical-stage biopharmaceutical company...
Microbiotica unveils new data on MB097 at AACR IO meeting
Data presented in Los Angeles showcases therapy’s potential Microbiotica, a clinical-stage biopharma company, has presented new data on MB097 at...
Mitazalimab shows promising survival rates in cancer study
Updated data from phase 2 study reveals survival benefit Alligator Bioscience has announced updated results from its phase 2 OPTIMIZE-1...
Designing self-destructing bacteria to make effective tuberculosis vaccines
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with "kill...
Rishi Sunak joins Prostate Cancer Research as an ambassador
Former UK PM advocates for national screening programme Rishi Sunak has joined Prostate Cancer Research as an ambassador to champion...
